BOBBIE YOUNG: Open Payments
NPI 1811529100 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,846 in 122 payments from 48 companies in 2025. Trend: 2023 $3,265 · 2024 $2,657 · 2025 $2,846
Food & beverage: $2,846
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $238 |
| Merck Sharp & Dohme LLC | 8 | $183 |
| Novartis Pharmaceuticals Corporation | 6 | $182 |
| Regeneron Healthcare Solutions, Inc. | 6 | $156 |
| GENZYME CORPORATION | 4 | $121 |
| Stemline Therapeutics Inc. | 5 | $120 |
| JAZZ PHARMACEUTICALS INC. | 3 | $113 |
| GlaxoSmithKline, LLC. | 5 | $102 |
| Daiichi Sankyo Inc. | 4 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $101 |
Products named: KISQALI, KEYTRUDA, LIBTAYO, ZEPZELCA, IBRANCE, Enhertu, RYTELO, Nubeqa.
Industry payments across GA — which companies pay providers there.
